These treatments work in different ways to help you lose weight and improve your health
Headache is also reported as an adverse effect in clinical trials of tirzepatide and other drugs in this class, such as semaglutide products (Ozempic and Wegovy) and liraglutide brands (like Saxenda), but individual responses vary
The protocols described represent commonly reported approaches rather than medical prescriptions
AstraZeneca had no role in the study design, conduct, collection, management, analysis, and interpretation of the data or the manuscripts preparation, review, or approval
A randomized trial in 2022 revealed that Wegovy-treated patients experienced a significant 15.8% reduction in body weight compared to Saxendas 6.4% in a 68-week study
Vasodilator effect of glucagon: Receptorial crosstalk among glucagon, GLP-1, and receptor for glucagon and GLP-1